Clinical Trial Update: EFICAC-TTR Trial: Exercise and Nutritional Supplementation in Transthyretin Cardiac Amyloidosis [NA]

View source ↗

Summary

This clinical trial in transthyretin amyloid cardiomyopathy studies exercise and nutritional supplementation. The study status is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Transthyretin Amyloid Cardiomyopathy

Snippet

Sponsor: Universidad de Burgos | Conditions: Transthyretin Cardiac Amyloidosis | NA | Status: NOT_YET_RECRUITING